Cell death signalling mechanisms in heart failure

Experimental and Clinical Cardiology

Volumn 16, Issue 4, 2011, Pages 102-108

  Mughal, Wajihah ^a   Kirshenbaum, Lorrie A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Apoptosis; Cell death; Heart failure; Mitochondria; Programmed necrosis

Indexed keywords

BIM PROTEIN; CASPASE; CELL PROTEIN; DNA; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN BID; PROTEIN BNIP3; PROTEIN NIX; PUMA PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOPHAGY; DNA DAMAGE; ENDOPLASMIC RETICULUM STRESS; HEART FAILURE; HEART MITOCHONDRION; HEART MUSCLE NECROSIS; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; OXIDATIVE STRESS; REVIEW; UNFOLDED PROTEIN RESPONSE;

EID: 80055119233     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (146)

1. Tarride J, Lim M, DesMeules M, et al. A review of the cost of cardiovascular disease. Can J Cardiol 2009;6:195-202.
2. Sacco RL. The new American Heart Association 2020 goal: Achieving ideal cardiovascular health. J Cardiovasc Med (Hagerstown) 2011;4:255-7.
3. Thomas JR, Clark AM. Women with heart failure are at high psychosocial risk: A systematic review of how sex and gender influence heart failure self-care. Cardiol Res Pract 2011;2011:91873.
4. Damman K, Maass AH, van der Meer P. Heart failure highlights in 2010. Eur J Heart Fail 2011;4:358-63.
5. Tsukada M, Ohsumi Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett 1993;333:169-74. (Pubitemid 23306962)
6. Kuma A, Hatano M, Matsui M, et al. The role of autophagy during the early neonatal starvation period. Nature 2004;432:1032-6. (Pubitemid 40052234)
7. Shaw J, Kirshenbaum LA. Molecular regulation of autophagy and apoptosis during ischemic and non-ischemic cardiomyopathy. Autophagy 2008;4:427-34. (Pubitemid 351705139)
8. Takemura G, Miyata S, Kawase Y, Okada H, Maruyama R, Fujiwara H. Autophagic degeneration and death of cardiomyocytes in heart failure. Autophagy 2006;2:212-4. (Pubitemid 44030886)
9. Essick EE, Sam F. Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer. Oxid Med Cell Longev 2010;3:168-77.
10. Beau I, Mehrpour M, Codogno P. Autophagosomes and human diseases. Int J Biochem Cell Biol 2011;43:460-4.
11. Decker RS, Wildenthal K. Lysosomal alterations in hypoxic and reoxygenated hearts. I. Ultrastructural and cytochemical changes. Am J Pathol 1980;98:425-44. (Pubitemid 10095799)
12. Danon MJ, Carpenter S, Manaligod JR, Schliselfeld LH. Fatal infantile glycogen storage disease: Deficiency of phosphofructokinase and phosphorylase b kinase. Neurology 1981;31:1303-7. (Pubitemid 11026849)
13. Riggs JE, Schochet SS Jr, Gutmann L, Shanske S, Neal WA, DiMauro S. Lysosomal glycogen storage disease without acid maltase deficiency. Neurology 1983;33:873-7. (Pubitemid 13066685)
14. Nishino I, Fu J, Tanji K, et al. Lamp-2 deficiency causes X-linked cardiomyopathy and myopathy (Danon disease). Nature 2000;406:906-10. (Pubitemid 30664268)
15. Saftig P, Tanaka Y, Lüllmann-Rauch R, von Figura K. Disease model: LAMP-2 enlightens Danon disease. Trends Mol Med 2001;7:37-9. (Pubitemid 33718081)
16. Zhu H, Tannous P, Johnstone JL, et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007;117:1782-93. (Pubitemid 47036312)
17. Cao DJ, Wang ZV, Battiprolu PK, et al. Histone deactylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci USA 2011;108:4123-8.
18. Hariharan N, Zhai P, Sadoshima J. Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid Redox Signal 2011;14:2179-90.
19. Valentim L, Laurence KM, Townsend PA, et al. Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol 2006;40:846-52. (Pubitemid 43817043)
20. Noh HS, Shin IW, Ha JH, Hah YS, Baek SM, Kim DR. Propofol protects the autophagic cell death induced by the ischemia/reperfusion injury in rats. Mol Cells 2010;30:455-60.
21. Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y. Dynamics and diversity in autophagy mechanisms: Lessons from yeast. Nat Rev Mol Cell Biol 2009;10:458-67.
22. Inoue Y, Klionsky DJ. Regulation of macroautophagy in Saccharomyces cerevisiae. Semin Cell Dev Biol 2010;21:664-70.
23. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000;290:1717-21. (Pubitemid 32004796)
24. Xie Z, Klionsky DJ. Autophagosome formation: Core machinery and adaptations. Nat Cell Biol 2007;9:1102-9. (Pubitemid 47500484)
25. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized to autophagosome membranes after processing. EMBO J 2000;19:5720-8.
26. Luzio JP, Pryor PR, Bright NA. Lysosomes: Fusion and function. Nat Rev Mol Cell Biol 2007;8:622-32. (Pubitemid 47106614)
27. Yu L, McPhee CK, Zheng L, et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010;465:942-6.
28. Pous C, Codogno P. Lysosome positioning coordinates mTORC1 activity and autophagy. Nat Cell Biol 2011;13:342-4.
29. Zeng X, Overmeyer JH, Maltese WA. Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci 2006;119:259-70. (Pubitemid 43210695)
30. Liang XH, Kleeman LK, Jiang HH, et al. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 1998;72:8586-96. (Pubitemid 28471796)
31. Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005;122:927-39. (Pubitemid 41345209)
32. Zalckvar E, Berissi H, Mizrachy L, et al. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Rep 2009;10:285-92.
33. Ciechomska IA, Goemans CG, Tolkovsky AM. Why doesn't Beclin 1, a BH3-only protein, suppress the anti-apoptotic function of Bcl-2? Autophagy 2009;5:880-1.
34. Zhu Y, Zhao L, Liu L, et al. Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis. Protein Cell 2010;1:468-77.
35. Djavaheri-Mergny M, Maiuri MC, Kroemer G. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 2010;29:1717-9.
36. Goljan EF. Rapid Review: Pathology, 3rd edn. Philadelphia: Mosby Elsevier, 2010.
37. Du Pasquier D, Rincheval V, Sinzelle L, et al. Developmental cell death during Xenopus metamorphosis involves BID cleavage and caspase 2 and 8 activation. Dev Dyn 2006;235:2083-94. (Pubitemid 44205045)
38. Crocoll A, Herzer U, Ghyselinck NB, Chambon P, Cato AC. Interdigital apoptosis and downregulation of BAG-1 expression in mouse autopods. Mech Dev 2002;111:149-52. (Pubitemid 34136987)
39. Kinchen JM. A model to die for: Signaling to apoptotic cell removal in worm, fly and mouse. Apoptosis 2010;15:998-1006.
40. Kerr JF. History of the events leading to the formulation of the apoptosis concept. Toxicology 2002;181-182:471-4. (Pubitemid 36015740)
41. Regula KM, Kirshenbaum LA. Apoptosis of ventricular myocytes: A means to an end. J Mol Cell Cardiol 2005;38:3-13. (Pubitemid 40038648)
42. De Moissac D, Gurevich RM, Zheng H, Singal PK, Kirshenbaum LA. Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol 2000;32:53-63. (Pubitemid 30064304)
43. Kim SJ, Kuklov A, Crystal GJ. In vivo gene delivery of XIAP protects against myocardial apoptosis and infarction following ischemia/ reperfusion in conscious rabbits. Life Sci 2011;88:572-7.
44. Prech M, Marszałek A, Schröder J, et al. Apoptosis as a mechanism for the elimination of cardiomyocytes after acute myocardial infarction. Am J Cardiol 2010;105:1240-5.
45. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-9. (Pubitemid 26339772)
46. Walker NI, Harmon BV, Gobé GC, Kerr JF. Patterns of cell death. Methods Achiev Exp Pathol 1988;13:18-54.
47. Weidman D, Shaw J, Bednarczyk J, et al. Dissecting apoptosis and intrinsic death pathways in the heart. Methods Enzymol 2008;446:277-85.
48. Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am J Pathol 1990;136:593-608. (Pubitemid 20105927)
49. Wyllie AH, Arends MJ, Morris RG, Walker SW, Evan G. The apoptosis endonuclease and its regulation. Semin Immunol 1992;4:389-97.
50. Denault JB, Salvesen GS. Apoptotic caspase activation and activity. Methods Mol Biol 2008;414:191-220.
51. Salvesen GS, Dixit VM. Caspases: Intracellular signaling by proteolysis. Cell 1997;91:443-6. (Pubitemid 27508233)
52. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 1998;273:2926-30. (Pubitemid 28133943)
53. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-78. (Pubitemid 24006113)
54. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 1991;138:447-53.
55. Pan G, O'Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science 1997;276;111-3. (Pubitemid 27161256)
56. Fuchs P, Strehl S, Dworzak M, Himmler A, Ambros PF. Structure of the human TNF receptor 1 (p60) gene (TNFR1) and localization to chromosome 12p13 [corrected]. Genomics 1992;13:219-24.
57. Sheridan JP, Marsters SA, Pitti RM, et al. Control of TRAILinduced apoptosis by a family of signaling and decoy receptors. Science 1997;277:818-21. (Pubitemid 27366733)
58. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505-12.
59. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996;84:299-308. (Pubitemid 26042835)
60. Pollard TD, Earnshaw WC, Lippincott-Schwartz J. Cell Biology, 2nd edn. Philadephia: Saunders Elsevier, 2008.
61. Marchetti P, Castedo M, Susin SA, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996;184:1155-60. (Pubitemid 26313572)
62. Petronilli V, Penzo D, Scorrano L, Bernardi P, Di Lisa F. The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem 2001;276:12030-4.
63. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000;102:33-42.
64. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-6.
65. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001;412:95-9. (Pubitemid 32851517)
66. Deveraux QL, Stennicke HR, Salvesen GS, Reed JC. Endogenous inhibitors of caspases. J Clin Immunol 1999;19:388-98. (Pubitemid 30039106)
67. Verhagen AM, Ekert PG, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000;102:43-53.
68. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:405-13. (Pubitemid 27347231)
69. Purring-Koch C, McLendon G. Cytochrome c binding to Apaf-1: The effects of dATP and ionic strength. Proc Natl Acad Sci USA 2000;97:11928-31.
70. Jiang X, Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 2000;275:31199-203.
71. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-3. (Pubitemid 15041322)
72. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C elegans. Cell 1986;44:817-29. (Pubitemid 16045328)
73. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994;369:321-3. (Pubitemid 24159542)
74. Hsu SY, Kaipia A, McGee E, Lomeli, Hsueh AJ. Bok is a proapoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc Natl Acad Sci USA 1997;94:12401-6. (Pubitemid 27492540)
75. Kirshenbaum LA, de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 1997;96:1580-5. (Pubitemid 27375355)
76. Gustafsson AB, Gottlieb RA. Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 2007;292:C45-C51. (Pubitemid 46115120)
77. Regula KM, Ens K, Kirshenbaum LA. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 2002;91:226-31. (Pubitemid 34875677)
78. Sassone J, Colciago C, Marchi P, et al. Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3). Cell Death Dis 2010;1:e7.
79. Anantharam V, Lehrmann E, Kanthasamy A, et al. Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: Relevance to oxidative damage in Parkinson's disease. Neurochem Int 2007;50:834-47. (Pubitemid 46722646)
80. Prabhakaran K, Chapman GD, Gunasekar PG. BNIP3 up-regulation and mitochondrial dysfunction in manganese-induced neurotoxicity. Neurotoxicology 2009;30:414-22.
81. Zhang Z, Shi R, Weng J, et al. The proapoptotic member of the Bcl-2 family Bcl-2 / E1B-19K-interacting protein 3 is a mediator of caspase-independent neuronal death in excitotoxicity. FEBS J 2011;278:134-42.
82. Kammouni W, Wong K, Ma G, Firestein GS, Gibson SB, El-Gabalawy HS. Regulation of apoptosis in fibroblast-like synoviocytes by the hypoxia-induced Bcl-2 family member Bcl-2/ adenovirus E1B 19-kd protein-interacting protein 3. Arthritis Rheum 2007;56:2854-63. (Pubitemid 47502731)
83. Giatromanolaki A, Koukourakis MI, Gatter KC, Harris AL, Sivridis E. BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1 alpha pathway and prognosis. J Clin Pathol 2008;61:217-20. (Pubitemid 351218884)
84. Edwards RA, Witherspoon M, Wang K, et al. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. Cancer Res 2009;69:6423-9.
85. Galvez AS, Brunskill EW, Marreez Y, et al. Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress. J Biol Chem 2006;281:1442-8.
86. Yurkova N, Shaw J, Blackie K, et al. The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes. Circ Res 2008;102:472-9. (Pubitemid 351651108)
87. Kubli DA, Quinsay MN, Huang C, Lee Y, Gustafsson AB. Bnip3 functions as a mitochondrial sensor of oxidative stress duringmyocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2008;295:H2025-H2031.
88. Dobson CM. Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 2004;15:3-16. (Pubitemid 38177363)
89. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-29. (Pubitemid 46985379)
90. Anelli T, Sitia R. Protein quality control in the early secretory pathway. EMBO J 2008;27:315-27. (Pubitemid 351161662)
91. Schröder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005;74:739-89. (Pubitemid 40995523)
92. Meusser B, Hirsch C, Jarosch E, Sommer T. ERAD: The long road to destruction. Nat Cell Biol 2005;7:766-72. (Pubitemid 41079045)
93. Malhotra JD, Miao H, Zhang K, et al. Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc Natl Acad Sci USA 2008;105:18525-30.
94. Shimazaki H, Watanabe K, Veeraveedu PT, et al. The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis. Free Radic Res 2010;44:1082-90.
95. Breckeridge DG, Germain M, Mathai JP, Nguyen M, Shore GC. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 2003;22:8608-18. (Pubitemid 38019196)
96. Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 2004;11:372-80. (Pubitemid 38489415)
97. Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: Cell life and death decisions. J Clin Invest 2005;115:2656-64. (Pubitemid 41434389)
98. Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 2004;11:372-80. (Pubitemid 38489415)
99. Mukherjee A, Soto C. Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress. Curr Opin Cell Biol 2011;23:223-30.
100. Hotamisligil GS. Endoplasmic reticulum stress and inflammatory basis of metabolic disease. Cell 2010;140:900-17.
101. Ribeiro CM, Boucher RC. Role of endoplasmic reticulum stress in cystic fibrosis-related airway inflammatory responses. Proc Am Thorac Soc 2010;7:387-94.
102. Yamaguchi O, Higuchi Y, Hirotani S, et al. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc Natl Acad Sci USA 2003;100:15883-8. (Pubitemid 38021084)
103. Thuerauf DJ, Marcinko M, Gude N, Rubio M, Sussman MA, Glembotski CC. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ Res 2006;99:275-82. (Pubitemid 44174935)
104. Wu T, Dong Z, Geng J, et al. Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats. Eur J Pharm Sci 2011;42:496-502.
105. Glembotski CC. The role of the unfolded protein response in the heart. J Mol Cell Cardiol 2008;44:453-9. (Pubitemid 351374700)
106. Minamino T, Komuro I, Kitakaze M. Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ Res 2010;107:1071-82.
107. Gething MJ. Role and regulation of the ER chaperone BiP. Semin Cell Dev Biol 1999;10:465-72.
108. Hendershot LM. BiP a master regulator of ER function. Mt Sinai J Med 2004;71:289-97.
109. Bertolotti A, Zhang Y, Hendershot, LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2000;2:326-32.
110. Bernales S, Papa FR, Walter P. Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol 2006;22:487-508.
111. Oyadomari S, Koizumi A, Takeda K, et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest 2002;109:525-32. (Pubitemid 34171784)
112. Yamamoto K, Yoshida H, Kokame K, Kaufman RJ, Mori K. Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. J Biochem 2004;136:343-50. (Pubitemid 39545794)
113. Yoshida H, Okada T, Haze K, et al. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol Cell Biol 2000;20:6755-67.
114. Sawada T, Minamino T, Fu HY, et al. X-box binding protein 1 regulates brain natriuretic peptide through a novel AP1/CRE-like element in cardiomyocytes. J Mol Cell Cardiol 2010;48:1280-9.
115. Belmont PJ, Chen WJ, San Pedro MN, et al. Roles for endoplasmic reticulum-associated degradation and the novel endoplasmic reticulum stress response gene Derlin-3 in the ischemic heart. Circ Res 2010;106:307-16.
116. Szegezdi E, Duffy A, O'Mahoney ME, et al. ER stress contributes to ischemia-induced cardiomyocyte apoptosis. Biochem Biophys Res Commun 2006;349:1406-11. (Pubitemid 44416413)
117. Matindale JJ, Fernandez R, Thueraf D, et al. Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ Res 2006;98:1186-93. (Pubitemid 43948105)
118. Sun Y, Liu G, Song T, et al. Upregulation of GRP78 and caspase-12 in diastolic failing heart. Acta Biochim Pol 2008;55:511-6.
119. Xin W, Li X, Lu X, Niu K, Cai J. Involvement of endoplasmic reticulum stress-associated apoptosis in a heart failure model induced by chronic myocardial ischemia. Int J Mol Med 2011;27:503-9.
120. Miyazaki Y, Kaikita K, Endo M, et al. C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation. Arterioscler Thromb Vasc Biol 2011;31:1124-32.
121. Nozaki S, Sledge Jr GW, Nakshatri H. Repression of GADD153/ CHOP by NF-kappaB: A possible cellular defense against endoplasmic reticulum stress-induced cell death. Oncogene 2001;20:2178-85. (Pubitemid 32424012)
122. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 2001;21:1249-59. (Pubitemid 32114973)
123. Puthalakath H, O'Reilly LA, Gunn P, et al. ER stress triggers apoptosis by activating BH3-only protein. Bim Cell 2007;129:1337-49. (Pubitemid 46962086)
124. Fu HY, Okada K, Liao Y, et al. Ablation of C/EBP homologous protein attenuates endoplasmic reticulum-mediated apoptosis and cardiac dysfunction induced by pressure overload. Circulation 2010;122:361-9.
125. Nickson P, Toth A, Erhardt P. PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress. Cardiovasc Res 2007;73:48-56. (Pubitemid 44937185)
126. Hetz C, Bernasconi P, Fisher J, et al. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science 2006;312:572-6.
127. Yang W, Tiffany-Castiglioni E, Koh HC, Son IH. Paraquat activates the IRE1/ASK1/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells. Toxicol Lett 2009;191:203-10.
128. Homma K, Katagiri K, Nishitoh H, Ichijo H. Targeting ASK1 in ER stress-related neurodegenerative diseases. Expert Opin Ther Targets 2009;13:653-64.
129. Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000;403:98-103. (Pubitemid 30038529)
130. Liu Q, Sargent MA, York AJ, Molkentin JD. ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice. Circ Res 2009;105:1110-7.
131. 2+: A control point for apoptosis. Science 2003;300:135-9.
132. Simmen T, Aslan JE, Blagoveshchenskaya AD, et al. PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis. EMBO J 2005;24:717-29. (Pubitemid 40396102)
133. Szabadkai G, Bianchi K, Várnai P, et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+channels. J Cell Biol 2006;175:901-11. (Pubitemid 44969196)
134. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980;68:251-306. (Pubitemid 11219226)
135. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998;60:619-42. (Pubitemid 28157889)
136. Vanlangenakker N, Vanden Berghe T, Krysko DV, Festjens N, Vandenabeele P. Molecular mechanisms and pathophysiology of necrotic cell death. Curr Mol Med 2008;8:207-20. (Pubitemid 351982539)
137. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
138. Golstein P, Kroemer G. Cell death by necrosis: Towards a molecular definition. Trends Biochem Sci 2007;32:37-43. (Pubitemid 46043552)
139. Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005;1:112-9.
140. Cho YS, Challa S, Moquin D, et al. Phosphorylaton-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus induced-inflammation. Cell 2009;137:1112-23.
141. Rosenbaum DM, Degterev A, David J, et al. Necroptosis, a novel form of caspase-independent cell death contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 2010;88:1569-76.
142. Trichonas G, Murakami Y, Thanos A, et al. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci USA 2010;107:1695-700.
143. Zhu S, Zhang Y, Bai G, Li H. Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's Disease. Cell Death Dis 2011;2:e115.
144. You Z, Savitz SI, Yang J, et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metabol 2008;28:1564-73.
145. Northington FJ, Chavez-Valdez R, Graham EM, Razsan S, Gauda EB, Martin LJ. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 2011;31:178-89.
146. Smith CCT, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, Yellon DM. Necrostatin: A potentially novel cardioprotective agent? Cardiovasc Drugs Ther 2007;21:221-33.